[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10312]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4722]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated October 20, 2009, and published in the Federal 
Register on October 28, 2009 (74 FR 55583), Formulation Technologies 
LLC., 11501 Domain Drive, Suite 130, Austin, Texas 78758, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Fentanyl (9801), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
analytical characterization, secondary packaging, and for distribution 
to clinical trial sites.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Formulation Technologies LLC., to import the basic 
class of controlled substance is consistent with the public interest, 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Formulation Technologies LLC., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-4722 Filed 3-4-10; 8:45 am]
BILLING CODE 4410-09-P